Navigation Links
Hall of Fame Shortstop Cal Ripken, Jr. Renews Commitment to Lung Cancer
Date:2/26/2008

Baseball's Ironman Remains Honorary Spokesperson for Lung Cancer Alliance

WASHINGTON, Feb. 26 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) proudly announced the continuation of its Face in the Fight campaign featuring Hall of Fame Orioles' Shortstop, Cal Ripken, Jr. Ripken continues to headline a nationwide awareness campaign focused on educating the public about lung cancer.

Ripken, known as the Ironman because of his consecutive games streak, lost his father to the disease just weeks before Opening Day in 1999. Ripken joined LCA as a spokesperson in 2007 and renewed his commitment to bring much needed attention to the disease for 2008.

"I am proud to work with Lung Cancer Alliance to help reverse the stigma surrounding the disease," said Ripken. "For too long, lung cancer has been ignored and those diagnosed have been blamed. Lung cancer survivors deserve to be treated with compassion and support regardless of their smoking history."

Lung cancer is the number one cancer killer, killing more Americans each year than breast, prostate and colon cancers--combined. It will take the lives of twice as many women as breast cancer and three times as many men as prostate cancer. Over 60 percent of those diagnosed with lung cancer either quit smoking decades ago or never smoked at all.

"By speaking out about lung cancer, Cal Ripken, Jr. will help bring about the compassion and support so needed for this community," said Laurie Fenton Ambrose, LCA President & CEO. "We graciously thank him for his leadership and commitment to this cause."

The Face in the Fight campaign includes print, broadcast, and radio Public Service Announcements. For more information and to download the PSAs for distribution please visit http://www.lungcanceralliance.org.

Lung Cancer Alliance (http://www.lungcanceralliance.org) is the only national non-profit organization dedicated solely to patient support and advocacy for those living with or at risk for lung cancer. LCA is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

CONTACT: Kay Cofrancesco of Lung Cancer Alliance, +1-202-744-1541, kay@lungcanceralliance.org


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wiley-Blackwell renews carbon neutral commitment
2. St. Marys Medical Center Renews RCM & Technology With MED3000
3. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
4. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
5. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
6. Heart Association Renews Call for CPR Training
7. FDA Renews Warnings on Pain-Relief Patch
8. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
9. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
10. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
11. NIH/NCI renews and extends nationwide license for Genomatix software and databases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live From ... the year’s best in pioneering, inventive, and ultimately successful projects undertaken by the ...
(Date:12/7/2016)... ... ... "ProBrand Flip allows FCPX editors to create unique logo reveals which can ... Film Studios. , ProBrand Flip includes 30 flip book reveal animations. Easily reveal any ... variety of flip book animations. In Addition, users can modify each preset to fit ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute ... the treatment modalities available in a single device. The announcement is part ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an ... not a one hour a week showing of hands. “The Road To Restoration” is ... “Perhaps you are familiar with the brass ring that you could reach out for, ...
(Date:12/7/2016)... ... ... “Walking With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, ... God's direction in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” ... , Sanford says, “I enjoy sharing the true stories in my book ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology: